Abstract
Background Deprived communities, migrant and ethnic minorities were disproportionately affected by COVID-19 and may, therefore, be at a higher risk of post-COVID condition (PCC). This analysis, using data from the Virus Watch study, investigates how deprivation, migration status, and ethnic minority status influence PCC risk in both the full cohort (all regardless of infection status) and those with a confirmed COVID-19 infection.
Methods A subset of participants from Virus Watch, a prospective community cohort study in England, were included. We used logistic regression to compare the predicted probability of developing PCC in both full and infected cohorts among different deprivation levels, migration and ethnic minority status categories by sex-at-birth during pre-Omicron and Omicron periods, adjusting for socio-demographic covariates.
Results During the pre-Omicron period, PCC probability increased with deprivation levels, especially in females (most deprived: 7.8%, 95% CI 4.6-11.0%; least deprived: 3.5%, 2.5-4.5%). Migrant and ethnic minority males had a higher likelihood of PCC than their respective counterparts, particularly in the full cohort for migrants (6.3%, 1.8-10.8%) and the previously infected cohort for ethnic minorities (38.8%, 21.2-56.4%). However, these disparities were less pronounced in females. In the Omicron period, these differential probabilities were also less evident.
Conclusion Our findings suggest that greater PCC probability among these populations is driven by increased infection risk and post-infection determinants. This underscores the need for policies and interventions to reduce infection risk and affordable and easily available healthcare services for those with PCC.
What is already known on this topic
Deprived, migrant, and ethnic minority groups experienced disproportionate rates of SARS-CoV-2 infection, hospitalisation and death due to a range of socioeconomic factors.
Emerging evidence suggests that individuals living in deprived areas may have a higher risk of developing post COVID condition (PCC), while mixed results were reported in research on PCC risk in ethnic minorities.
There is limited evidence on the association between migration status and PCC.
What this study adds
During the pre-Omicron period, more deprived populations were associated with increased PCC probability, especially among females. Migrant, ethnic minority and migrant-ethnic minority males also had higher PCC probability compared to their counterparts after accounting for potential confounders.
In the Omicron period, the disparities in the likelihood of PCC were less pronounced, though migrant-ethnic minority females still had higher PCC probability, especially in those with confirmed infections, suggesting post-infection determinants play a role.
Our study suggests pre- and post-infection determinants of PCC among these populations.
How this study might affect research, practice or policy
This study underscores the need to address health inequalities faced by deprived, migrant and ethnic minority populations to reduce their risk of COVID-19 infection and PCC.
Further research into the intersection of migration, ethnicity, and deprivation, along with other factors such as sex and occupation, is required to guide targeted public health efforts and resource allocation.
Target policies should address occupational and housing exposure risks, increase vaccine uptake, provide culturally appropriate public health information and ensure equitable access to PCC and primary care services
Competing Interest Statement
ACH serves on the UK New and Emerging Respiratory Virus Threats Advisory Group. The other authors declare no potential conflict of interest.
Funding Statement
This work was supported by the Medical Research Council [Grant Ref: MC_PC 19070] awarded to UCL on 30 March 2020 and Medical Research Council [Grant Ref: MR/V028375/1] awarded on 17 August 2020. The study also received $15,000 of advertising credit from Facebook to support a pilot social media recruitment campaign on 18th August 2020. This study was supported by the Wellcome Trust through a Wellcome Clinical Research Career Development Fellowship to RWA [206602]. IB is supported by an NIHR Academic Clinical Fellowship. From 1 May 2022 Virus Watch received funding from the European Union (Project: 101046314). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of the Hampstead NHS Health Research Authority Ethics Committee gave ethical approval for Virus Watch: 20/HRA/2320. Virus Watch conformed to the ethical standards set out in the Declaration of Helsinki. Participants provided informed consent for all aspects of the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.